EcoPhage has announed today that it was the first to present at the Open4Ag event by Bayer. EcoPhage’s proprietary technological platform is licensed from the Weizmann Institute of Science, developed by Professor Rotem Sorek, a recognized world leader known for his groundbreaking research on the interactions between bacteria and bacteriophages. The technology consists of screening and characterization methodology of phage collections, resulting in the selection of
the most promising phage candidates (“super phages”). These phages form a basis for highly effective and sustainable phage cocktails that meet multiple agricultural product attributes for antimicrobial crop protection.
The company is backed by The Trendlines Group, the Bayer Trendlines Ag Innovation Fund and the Israel Innovation Authority.
Bayer has launched a new program allowing research scientists from around the world to submit novel chemistries to the company for testing in the hope of identifying potential new modes of action to control fungal diseases, insect pests, or weeds. The so called Testing4Ag program is part of Bayer’s Open4Ag partnership development and innovation approach, which seeks to develop the newest generation of crop protection products that safely and sustainably address the changing needs of producers.